For consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.

1 April 2009
Unexpected and conflicting findings of recent diabetes studies raise the question of how aggressively doctors should manage glucose control in people with type 2 diabetes.
In the latest edition of Australian Prescriber, Dr Kris Park, Head of Diabetes and Endocrinology at Nepean Hospital, cautions that aggressive therapy is not the best approach for all patients.
Dr Park's editorial summarises results of the ACCORD (Action to Control Cardiovascular Risk in Diabetes) and ADVANCE (Action in Diabetes and Vascular Disease) studies.
“In patients with a long duration of diabetes and established vascular disease, tight glycaemic control may not improve the cardiovascular outcomes. Rapid correction of hyperglycaemia and excessively tight glycaemic control appears harmful and should be avoided,” Dr Park warns.
Recommended blood glucose levels are given for high-risk individuals, and Dr Park notes the target can be adjusted for each patient with regular assessment for severe hypoglycaemic episodes and hypoglycaemia unawareness.
“The findings from the ACCORD and ADVANCE studies are important but they do not change the treatment goal for most patients with type 2 diabetes,” Dr Park writes.
“Optimal therapy for people with diabetes includes addressing not only glycaemic control, but also other coexisting vascular risk factors such as hypertension, lipid abnormalities and platelet dysfunction,” Dr Park concludes.
Also covered in this edition of Australian Prescriber is Prescribing in liver disease. Dr Andrew Sloss and Dr Paul Kubler of the Royal Brisbane Hospital discuss the need for the careful choice of drug and dose when prescribing for patients with hepatic impairment.
For full copies of the articles visit www.australianprescriber.com.
ENDS
Australian Prescriber is an independent peer-reviewed journal providing critical commentary on therapeutic topics for health professionals, particularly doctors in general practice. It is published by the National Prescribing Service Limited (NPS), an independent, non-profit organisation for Quality Use of Medicines funded by the Australian Government Department of Health and Ageing. Australian Prescriber is distributed every two months in hard copy to health professionals, free of charge, and online in full text at www.australianprescriber.com
Media enquiries
Contact us
Date published: 2009-04-01 00:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.